KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Gross Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 531.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -168.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 449.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 134.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -367.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 129.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -1,698.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -714.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -714.00
Dec 31, 2025 -1,004.00
Sep 30, 2025 -713.00
Jun 30, 2025 -460.00
Mar 31, 2025 -586.00
Dec 31, 2024 -1,933.00
Sep 30, 2024 -516.00
Jun 30, 2024 -582.00
Mar 31, 2024 95.00
Dec 31, 2023 237.00
Sep 30, 2023 89.00
Jun 30, 2023 103.00
Mar 31, 2023 1,133.00
Dec 31, 2022 863.00
Sep 30, 2022 882.00
Jun 30, 2022 855.00
Mar 31, 2022 960.00
Dec 31, 2021 730.00
Sep 30, 2021 925.00
Jun 30, 2021 754.00
Mar 31, 2021 485.00
Dec 31, 2020 309.00
Sep 30, 2020 632.00
Jun 30, 2020 386.00
Mar 31, 2020 -830.00
Dec 31, 2019 -455.00
Sep 30, 2019 -328.00
Jun 30, 2019 -668.00
Mar 31, 2019 -685.00
Dec 31, 2018 -475.00
Sep 30, 2018 -200.00
Jun 30, 2018 -416.00
Mar 31, 2018 -954.00
Dec 31, 2017 -669.00
Sep 30, 2017 -437.00
Jun 30, 2017 -502.00
Mar 31, 2017 -26.00
Dec 31, 2016 185.00
Sep 30, 2016 239.00
Jun 30, 2016 261.00
Mar 31, 2016 379.00
Dec 31, 2015 344.00
Sep 30, 2015 -54.00
Jun 30, 2015 369.00
Mar 31, 2015 385.00
Dec 31, 2014 238.00
Sep 30, 2014 64.00
Jun 30, 2014 177.00
Mar 31, 2014 140.00
Dec 31, 2013 -100.00
Sep 30, 2013 -223.00
Jun 30, 2013 -59.00
Mar 31, 2013 -58.00
Dec 31, 2012 282.00
Sep 30, 2012 109.00
Jun 30, 2012 -176.00
Mar 31, 2012 214.00